In a recent webinar titled "Decoding the Impact of Rogue Angiotensin System on Deteriorating Mitochondria," Dr. Peter Abadir, an associate professor of geriatric medicine at Johns Hopkins University and co-principal investigator at JH AITC, provided a thorough examination of the role of the rogue angiotensin system in mitochondrial deterioration within aging populations. Dr. Abadir opened his presentation with a perspective on the biological pathways that influence the well-being of older adults' physical and cognitive functions. He highlighted his work at the Johns Hopkins Bayview Medical Center, emphasizing a multidisciplinary approach to geriatric care. Dr. Abadir discussed how advancements in medication and technology have extended lifespans but also introduced complex health challenges. Key takeaways included the critical need for specialized training in geriatric care, the impact of the angiotensin system beyond blood pressure regulation, and the promising potential of targeted medications to improve conditions such as ALS. The webinar concluded with a discussion on the importance of incorporating key stakeholder engagement in the design of new technologies for older adults, illustrating the complexity and interconnectivity of treating aging populations.